EN
HI
Summary
As of 11 Sep, 2026, Indo US Bio-Tech stock price is ₹78.24. During the trading session, the stock has moved between an intraday low of ₹78.00 and an intraday high of ₹82.00. Over the last 52 weeks, Indo US Bio-Tech has traded between ₹70.00 and ₹159.00.
The stock has recorded a trading volume of 10,159 shares,. Its Average Traded Price (ATP) is ₹78.51, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 12 @ ₹78.24.
Indo US Bio-Tech has an upper circuit limit of ₹95.44 and a lower circuit limit of ₹63.64. The total value traded stands at ₹7.98 L, and the delivery percentage for the day is 44.97%.
The stock is currently traded with a market lot size of 1. Indo US Bio-Tech also offers a dividend yield of 0%.
Indo US Bio-Tech Share Price Chart
Indo US Bio-Tech Share Key Metrics
Volume
10159.00
Market Cap
156.89 CR
LTQ@LTP
12@78.24
ATP
78.51
Var Margin
24.65 %
Circuit Range
63.64-95.44
Delivery %
44.97 %
Value
7.98 L
ASM/GSM
No
Market Lot
1
Indo US Bio-Tech Fundamentals
P/E Ratio
30.79
P/B Ratio
0
Div. Yield
0
Sector P/E
31.13
Sector P/B
1.26
Sec. Div. Yield
0.21
Indo US Bio-Tech Resistance and Support
Pivot 79.6
Resistance
First Resistance
81.19
Second Resistance
82.84
Third Resistance
84.43
Support
First Support
77.95
Second Support
76.36
Third Support
74.71
Indo US Bio-Tech Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 82 | 78.24 | -1.63% | 82 | 78 |
| Thu Sep 10 2026 | 81.19 | 79.54 | -0.88% | 81.25 | 78.01 |
| Wed Sep 09 2026 | 81.33 | 80.25 | 1.79% | 81.33 | 78 |
Indo US Bio-Tech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-05-29 | Audited Results |
| 2026-01-21 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-10-14 | Others |
| 2025-08-12 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2024-11-21 | Interim Dividend |
| 2024-11-16 | Interim Dividend |
| 2024-11-14 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Indo US Bio-Tech News
Indo Us Bio-Tech Ltd - 541304 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 12, 2026, Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Indo Us Bio-Tech approved Q1 FY27 financial results. Revenue grew 7.2% YoY to ₹32.99 crore, but net profit declined 35.4% YoY to ₹3.04 crore. The standalone un-audited results were approved by the board on August 12, 2026.
Aug 12 2026 15:23:31
Indo US Bio-Tech Management
| Name | Position |
|---|---|
| Dimpy Joshi | Company Secretary & Compliance Officer |
| Jagdish Ajudia | Managing Director |
Indo US Bio-Tech FAQs
The Buying Price of Indo US Bio-Tech share is 78.24 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Indo US Bio-Tech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Indo US Bio-Tech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Indo US Bio-Tech shares is 30.79. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Indo US Bio-Tech shares is 0. Useful to assess the stock's value relative to its book value.
To assess Indo US Bio-Tech’s valuation compare Sector P/E, P/B which are 31.13 & 1.26 with sector averages, along with growth rates and financial metrics.
The Market Cap of Indo US Bio-Tech is 156.89 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Indo US Bio-Tech share price is 159.00 & 70.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Indo US Bio-Tech belongs to the Agriculture sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in INDOUS
